Guardian Capital (Canada)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-18,531
Closed -$762K 181
2019
Q2
$762K Sell
18,531
-241,634
-93% -$9.59M 0.01% 117
2019
Q1
$10.5M Sell
260,165
-20,316
-7% -$814K 0.19% 74
2018
Q4
$11.6M Sell
280,481
-15,063
-5% -$625K 0.24% 64
2018
Q3
$12.4M Buy
295,544
+741
+0.3% +$28.5K 0.21% 65
2018
Q2
$10.1M Buy
294,803
+32,212
+12% +$1.1M 0.17% 70
2018
Q1
$8.84M Buy
262,591
+29,985
+13% +$1.03M 0.15% 82
2017
Q4
$7.99M Sell
232,606
-208
-0.1% -$7.09K 0.12% 87
2017
Q3
$7.89M Sell
232,814
-1,845
-0.8% -$59.3K 0.12% 99
2017
Q2
$7.48M Sell
234,659
-1,766
-0.7% -$55.7K 0.12% 103
2017
Q1
$7.67M Sell
236,425
-1,235
-0.5% -$38.9K 0.12% 98
2016
Q4
$7.32M Sell
237,660
-11,176
-4% -$341K 0.11% 100
2016
Q3
$8M Sell
248,836
-29,692
-11% -$993K 0.13% 93
2016
Q2
$9.3M Buy
278,528
+17,217
+7% +$549K 0.15% 81
2016
Q1
$7.35M Sell
261,311
-86,482
-25% -$2.47M 0.12% 89
2015
Q4
$10.7M Buy
347,793
+29,823
+9% +$938K 0.2% 72
2015
Q3
$9.48M Sell
317,970
-2,649
-0.8% -$84.9K 0.18% 69
2015
Q2
$10.2M Buy
320,619
+56,062
+21% +$1.83M 0.17% 72
2015
Q1
$8.73M Sell
264,557
-9,348
-3% -$297K 0.15% 75
2014
Q4
$8.1M Sell
273,905
-52,075
-16% -$1.49M 0.13% 72
2014
Q3
$9.14M Sell
325,980
-9,083
-3% -$255K 0.14% 75
2014
Q2
$9.44M Sell
335,063
-49,027
-13% -$1.4M 0.14% 73
2014
Q1
$11.7M Sell
384,090
-21,577
-5% -$643K 0.18% 57
2013
Q4
$11.8M Buy
+405,667
New +$11.8M 0.19% 58

Other funds holding PFE

Guardian Capital (Canada)'s PFE Position: Q3 2019 in Review

Guardian Capital (Canada) sold out of Pfizer (PFE) in Q3 2019, closing a stake of 18,531 shares — an estimated $762K sold.

Guardian Capital (Canada) first reported a position in PFE in Q4 2013 and held it in 23 quarters. The position peaked at $12.4M in Q3 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Guardian Capital (Canada) reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • Guardian Capital (Canada) sold 18,531 Pfizer shares in Q3 2019, an estimated $762K.
  • Guardian Capital (Canada) first reported a position in Pfizer in Q4 2013 and held it in 23 quarters.
  • Guardian Capital (Canada)'s Pfizer position peaked at $12.4M in Q3 2018.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Guardian Capital (Canada)'s 13F filing for Q3 2019, filed 14 Nov 2019.